Aim: To investigate the effects of long-term low-carbohydrate low-protein ketogenic diet (KD) on cardiac metabolism and diabetic cardiomyopathy status in lean diabetic Goto-Kakizaki (GK) rats.
| INTRODUCTION
Diabetes is a risk factor for cardiovascular diseases. 1 A diabetic heart may develop cardiomyopathy despite the absence of underlying cardiovascular conditions, which can be attributed to its increased preference for fatty acid metabolism. 2 Indeed, heart failure development has also been associated with altered cardiac substrate metabolism. 3 Of note, the role of ketone bodies in cardiometabolic health has also been increasingly appreciated. 4, 5 Studies in both humans and animals reveal upregulation of myocardial ketone body utilization in advanced heart failure. 6, 7 However, it is not clear yet whether the increase in ketone body use in the failing heart is adaptive or maladaptive. In ischaemia-reperfusion experiments in rats, fasting-induced ketosis 8 and intravenous injection of β-hydroxybutyrate (β-OHB) 9 could attenuate ischaemic injury. In a recent clinical trial, the beneficial effect of sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin on cardiovascular outcome in patients with diabetes 10 was also thought to be associated with hyperketonemia. 11 However, recent studies showed that despite hyperketonemia, empagliflozin either lowered 12 or did not alter 13 myocardial ketone body utilization in rodent models of diabetes.
A ketogenic diet (KD) is becoming popular in the management of diabetes. 14 In patients, KD has been shown to induce body weight loss, although the benefits of KD may extend beyond body weight loss, such as reduction in cardiovascular disease (CVD) risk. [15] [16] [17] Interestingly, opposite effects of KD on CVD risks have also been reported in mice. [17] [18] [19] [20] [21] Despite the controversial findings on CVD risk, there is currently limited research on the impact of KD on heart physiology. A high-ketone, as well as low-carbohydrate and high-fat, environment induced by KD may trigger cardiac metabolic adaptations in the long term, which may or may not be beneficial in the diabetic heart. Here, we sought to investigate whether KD can modulate cardiac substrate metabolism and/or induce functional alterations in the diabetic heart. For this purpose, we used a lean rodent model of diabetes and diabetic cardiomyopathy, Goto-Kakizaki (GK) rats. [22] [23] [24] A lean diabetic model was chosen to reduce the confounding effects of obesity on the findings. is a powerful technique to study metabolism non-invasively in vivo.
We used hyperpolarized [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetoacetate as a novel probe for ketone body metabolism, 12 hyperpolarized [1- 13 C]butyrate as a probe for short chain fatty acid metabolism, 25 and [1- 13 C] pyruvate as a probe for glucose metabolism, 26 to comprehensively study the effects of cardiac metabolic modulations upon KD feeding (see pathways in Figure 1 ). Upon administration of the hyperpolarized probes, the production of downstream metabolites as a result of the metabolism of the 13 C substrate can be observed in real time using 13 C-MRS within 1 minute of substrate administration. 27 As an in vivo method, hyperpolarized 13 C-MRS allows investigation of cardiac metabolism in a more physiological condition compared with, for example, ex vivo perfused heart experiments. The in vivo and non-invasive nature of the technique also allows the measurements of the same animals under different conditions, for example, at rest or under stress conditions. In the present study, we stressed the heart using dobutamine, to detect abnormalities which may not be observed under resting conditions. 24 To complement the in vivo data, we also determined the expression of proteins involved in myocardial ketone body, fatty acid and glucose metabolism, as well as myocardial lipid content, fibrosis and oxidative stress.
| MATERIALS AND METHODS

| Animals
Male lean diabetic Goto-Kakizaki (GK/MolTac) rats bred by Taconic (New York) were purchased from InVivos (Singapore). Starting from 12 weeks of age, they were fed either chow diet (N = 4; Rat/Mouse
The effects of KD on cardiac substrate metabolism in diabetic rats as studied using hyperpolarized 13 C magnetic resonance spectroscopy (MRS). The metabolites in boxes (in pink, orange or blue) can be detected using 13 C-MRS after injection of hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C] pyruvate, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]butyrate or [3- 13 C]acetoacetate, respectively. Upward arrows, downward arrows or equals signs summarize the findings in the present study whether the production of the corresponding metabolites was higher, lower or equal, respectively, in the KD-fed diabetic rats compared with that in the chow-fed diabetic rats, at rest or under stress condition. 
| Blood analysis
Serum samples were collected before dobutamine infusion and after 20 minutes of dobutamine infusion, and at a few time points during the study period (fed or fasted conditions). Blood glucose, triglycerides (TG) and β-OHB were determined using meters. Serum acetoacetate, free fatty acid (FFA), ANP and insulin were determined using assay kits (see the supporting information for this article).
| Ex vivo tissue analysis
The expression of proteins of interest was determined via Western blotting. Cardiac succinyl-CoA-3-oxaloacid CoA transferase (SCOT) activity was performed as described previously. 28 Cardiac pyruvate dehydrogenase (PDH) activity and cardiac triglyceride levels were determined using assay kits. Sirius Red histology was performed to assess fibrosis. The details of tissue analysis are provided in the supplementary materials (see the supporting information for this article). nificance was set at P < 0.05. Despite the small sample sizes, the power of the statistical analyses was more than 80%, because of the large magnitude of the differences observed between KD-fed and chow-fed animals (Table S1 ).
| Statistics
3 | RESULTS
| KD affected body weight and blood parameters
Initially, KD resulted in lower body weight in KD-fed diabetic rats than in chow-fed diabetic rats (P < 0.05 at 6, 19, 24 and 28 weeks of diet; Figure S1 ). However, body weight was not different between the two groups after 33 weeks of diet ( Figure S1 ). In KD-fed diabetic rats, fed blood glucose, insulin and TG levels were lower compared with chow-fed diabetic rats, while fasting glucose and TG levels were not different between KD-fed diabetic rats and chow-fed diabetic rats (Table 1 and Figure S1 ). As expected, KD-fed diabetic rats had higher expression of liver 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2), a protein involved in ketogenesis, which resulted in higher fed and fasted blood β-OHB, fed serum acetoacetate, and fed serum FFA levels in KD-fed diabetic rats than in chow-fed diabetic rats (Table 1 and Figure 2F ,G).
| KD attenuated dobutamine-induced enddiastolic volume decrease
At rest, there was no difference in cardiac function parameters between KD-fed diabetic rats and chow-fed diabetic rats (Table 2) .
Dobutamine infusion resulted in a 25% increase in heart rate and in ejection fraction independent of diet ( Table 2 ). Dobutamine reduced end-diastolic volume (EDV) (P < 0.001 in chow-fed diabetic rats, P = 0.030 in KD-fed diabetic rats) and end-systolic volume (ESV, independent of diet; Table 2 ). However, there was significantly less dobutamine-induced decrease in EDV in KD-fed diabetic rats than in chow-fed diabetic rats (−13% vs. −32%, P = 0.026), which indicates an increase in cardiac preload in KD-fed diabetic rats. Percentage decrease in ESV was similar in both groups (P = 0.95). Consequently, stroke volume (SV) under dobutamine was higher in KD-fed diabetic rats (P = 0.015 vs. chow-fed diabetic rats). Cardiac output (CO) was also higher in KD-fed diabetic rats, independent of dobutamine stress (Table 2) , which can be attributed to the numerically higher heart rate at rest and higher SV under dobutamine stress.
KD-fed diabetic rats exhibited higher heart weight/tibia length, left ventricular (LV) mass/tibia length, cardiomyocyte cross-sectional area, and serum ANP compared with those in chow-fed diabetic rats (Table 1) , suggesting cardiac hypertrophy induced by a ketogenic diet. Interestingly, in the hearts of KD-fed diabetic rats, gene expression of Nppa tended to be lower, while gene expressions of Nppb, Acta1 and Myh7 were significantly lower compared with those of chow-fed diabetic rats (Table 1 ).
| KD and dobutamine stress lowered myocardial ketone body oxidation in the TCA cycle
To investigate the effects of KD on cardiac ketone body metabolism, we performed cardiac At rest, KD-fed diabetic rats exhibited 34% lower [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glutamate production (P = 0.001 vs. chow-fed diabetic rats; Figure 2C ) and 42% lower [1-
13
C]acetylcarnitine production (general diet effect:
P < 0.001; Figure 2D ). On the other hand, [3-
C]β-OHB production Abbreviations: ACADL, acyl-CoA dehydrogenase; ANP, atrial natriuretic peptide; BDH1, 3-hydroxybutyrate dehydrogenase 1; BNP, brain natriuretic peptide; β-OHB, β-hydroxybutyrate; CPT1B, carnitine palmitoyltransferase-1B; GLUT1/4, glucose transporter-1/4; HADH, 3-hydroxyacyl-CoA dehydrogenase; HMGCS2, 3-hydroxy-3-methylglutaryl-CoA synthase 2; PDH, pyruvate dehydrogenase; PKM1/2, pyruvate kinase isozyme M1/M2; SCOT, succinyl-CoA-3-oxaloacid CoA transferase; TG, triglycerides. Coefficient variations (CV) for intra-assay and inter-assay as reported by the manufacturer: ANP: <10% and < 15%, respectively; insulin: <2.9% and < 4.8%, respectively. Data are means ± SD (chow-fed diabetic rats N = 3-4, KD-fed diabetic rats N = 5-6). Student's t-test: *P < 0.05 vs. chow-fed diabetic rats. Images of blots and histological sections are provided in Figures S3 and S4 ,S5, respectively. Fasting values were measured after 16 hours of fasting. Fed blood values were determined at harvest. Other parameters were from organs collected at harvest at fed state. Left ventricle (LV) mass was determined from MRI measurements.
was 75% higher in KD-fed diabetic rats compared with chow-fed diabetic rats (P < 0.001; Figure 2E ). These data suggest lower myocardial ketone body utilization in KD-fed diabetic rats. In agreement, ex vivo SCOT activity was lower in the hearts of KD-fed diabetic rats compared with chow-fed diabetic rats ( Table 1 ). The expression of cardiac 3-hydroxybutyrate dehydrogenase 1 (BDH1), an enzyme involved in the first step of β-OHB conversion to acetoacetate, was also lower in KD-fed diabetic rats than in chow-fed diabetic rats (Table 1) .
Dobutamine decreased [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glutamate production by 47% in chow-fed diabetic rats (P < 0.001 vs. rest) and by 31% in KD-fed diabetic rats (P = 0.021 vs. rest; Figure 2C ), which indicates lower ketone body oxidation in the TCA cycle. Concomitantly, dobutamine increased [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetylcarnitine production by 51% (general dobutamine effect: P = 0.01; Figure 2D ). [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]β-OHB production was increased by 88% under dobutamine stress in chow-fed diabetic rats (P < 0.001 vs. rest), but not in KD-fed diabetic rats Abbreviations: bpm, beats per min; CO, cardiac output; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; HR, heart rate; SV, stroke volume. Chow-fed diabetic rats N = 4, KD-fed diabetic rats N = 6. When the interaction term P < 0.05, Bonferroni-corrected multiple comparisons were performed: *P < 0.05 vs. chow-fed diabetic rats under the same condition;^P < 0.05 vs. rest in the same diet group.
(P = 0.63 vs. rest; Figure 2E ), which suggests an increase in mitochondrial redox state in chow-fed diabetic rats as a response to dobutamine. Under dobutamine stress blood β-OHB levels were elevated by 176% in KD-fed diabetic rats (P < 0.001 vs. rest) and tended to increase by 90% in chow-fed diabetic rats (P = 0.08 vs. rest; Figure 2F ). Serum acetoacetate levels were 11% higher in KD-fed diabetic rats than in chow-fed diabetic rats (general diet effect: P < 0.001; Figure 2G ).
These data indicate that under stress, ketone bodies were not oxidized in the TCA cycle and were stored as acetylcarnitine or β-OHB. In agreement, there were no correlations between cardiac function and metabolic products of ketone body utilization ( Figure S2 ).
3.4 | KD did not affect myocardial short-chain fatty acid oxidation in the TCA cycle
We performed cardiac and general diet effect: P = 0.12, respectively; Figure 4C ,D). However, [ 13 C]bicarbonate production was 75% lower in KD-fed diabetic rats (P < 0.001 vs. chow-fed diabetic rats; Figure 4E ), which indicates lower PDH flux and lower glucose oxidation in KD-fed diabetic rats.
In agreement, ex vivo PDH activity was lower in the hearts of KD-fed diabetic rats than in those of chow-fed diabetic rats (Table 1) .
Dobutamine increased [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]lactate production by 195% in chow-fed diabetic rats (P < 0.001 vs. rest) and by 233% in KD-fed diabetic rats (P < 0.001 vs. rest; Figure 4C ). The higher increase in [1- 13 C]lactate production in KD-fed diabetic rats (P < 0.001 vs. chowfed diabetic rats) suggests a higher glycolytic rate in KD-fed diabetic rats under dobutamine stress. Dobutamine increased the production of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine in KD-fed diabetic rats and in chow-fed diabetic rats by 34% (general dobutamine effect: P = 0.016; Figure 4D ). The production of [ Figure 4H ).
We also determined the expression of proteins involved in glucose transport (i.e. insulin-dependent GLUT4 and insulin-independent GLUT1) and in glycolysis (i.e. PKM1 and PKM2). Interestingly, while KD consists of low carbohydrate content, the expression of GLUT4 was more upregulated in the hearts of KD-fed diabetic rats than in those of chow-fed diabetic rats, although GLUT1 was not affected by KD (Table 1 and Figure S3 ). The expression of PKM1 and PKM2 was also more upregulated in the hearts of KD-fed diabetic rats than in those of chow-fed diabetic rats (Table 1 and Figure S3 ).
| KD affected markers of fatty acid oxidation and myocardial lipotoxicity
The expression of acyl-CoA dehydrogenase (ACADL) and 3-hydroxyacyl-CoA dehydrogenase (HADH) was higher in KD-fed diabetic hearts than in those of chow-fed diabetic rats, while the expression of carnitine palmitoyltransferase-1B (CPT1B) was similar between the two groups ( Table 1) . Myocardial triglyceride content and collagen content tended to be 56% and 11% higher, respectively, in the hearts of KD-fed diabetic rats than in those of chow-fed diabetic rats (Table 1 and Figure S4 ). The expression of catalase, an antioxidant enzyme, doubled in the hearts of KD-fed diabetic rats compared with those of chow-fed diabetic rats (Table 1) , which indicated an elevation in oxidative stress.
| DISCUSSION
The shift in metabolic preference towards fatty acid utilization in the diabetic heart has been implicated in the development of diabetic cardiomyopathy. 2 Consequently, modulating cardiac metabolism to restore substrate balance in the diabetic heart has previously been shown to be cardioprotective. 29, 30 In the present study, we investigated how KD modulated cardiac metabolism in the heart of diabetic GK rats, and whether this was associated with alleviation of diabetic cardiomyopathy status. Previously, an increase in myocardial fatty acid utilization and a lower glucose uptake have indeed been shown in diabetic GK rats, together with cardiac hypertrophy and diastolic dysfunction. 23 Our study showed that KD seems to exacerbate diabetic cardiomyopathy status in the diabetic GK heart. High fat content in KD further shifted metabolic substrate imbalance towards fatty acid oxidation, as shown by higher expression of proteins involved in fatty acid oxidation and a trend for lipid accumulation in the hearts of KDfed diabetic rats compared with those of chow-fed diabetic rats. KD also further lowered the oxidation of glucose substrates in diabetic GK rats, as shown by lower myocardial pyruvate oxidation in KD-fed diabetic rats compared with that in chow-fed diabetic rats, which could be due to the low dietary carbohydrate availability and suppression of glucose oxidation by fatty acids (via Randle cycle). KD also increased cardiac preload and reduced cardiac compliance, as suggested by lower dobutamine-induced EDV decrease in KD-fed diabetic rats than in chow-fed diabetic rats, together with cardiac hypertrophy, oxidative stress, and a trend for cardiac fibrosis.
We showed that KD indeed induced liver ketogenesis, as evidenced by higher liver HMGCS2 expression as well as higher blood levels of ketone bodies (i.e. β-OHB and acetoacetate). Interestingly, we observed that the increase in ketone body availability did not translate into a higher ketone body use in the diabetic heart. Myocardial ketone body oxidation in the TCA cycle (as observed via the C]butyrate (data from a chow-fed diabetic rat at rest). B, Representative spectra of chow-fed and KDfed diabetic rats at rest summed over 60 spectra. Production of C, [1- General diet effect, independent of dobutamine:^P < 0.05 production of 13 C glutamate in vivo in the heart after injection of hyperpolarized 13 C acetoacetate), as well as total myocardial ketone body utilization (as observed via the production of 13 C glutamate and 13 C acetylcarnitine), were both lower in KD-fed diabetic rats than in chow-fed diabetic rats (summarized in Figure 1 , pathways in blue). In agreement, SCOT activity and BDH1 expression were lower in the hearts of KD-fed diabetic rats than in those of chow-fed diabetic rats.
We further confirmed the observation using hyperpolarized 13 C butyrate, in which the production of 13 C acetoacetate upon injection of 13 C butyrate was lower in KD-fed diabetic rats than in chow-fed diabetic rats (Figure 1, pathways in orange) . Thus, the hearts of KD-fed diabetic rats adapted to the abundant ketotic milieu by downregulating ketone body utilization. Our results of lower ketone body utilization in KD-fed rats concurred with previous work by Wentz et al., in which even a short period (i.e. 4 weeks) of KD feeding in mice resulted in a reduction in myocardial ketone body use. 31 The authors argued that this may be a compensatory mechanism to protect the TCA cycle. 31 A previous study by Russell and Taegtmeyer showed that acetoacetate oxidation impaired the TCA cycle by decreasing anaplerosis. 32 Furthermore, Wentz et al. showed that increased ketone body levels decreased the inhibitory effects of ketone bodies on fatty acid oxidation. 31 Considering that fatty acids are the main substrate in the heart, 33 this could also be a mechanism to reduce competition between fatty acids and ketone bodies, ensuring sufficient fatty acid oxidation in the heart.
A novel finding in this study was that under dobutamine stress, ketone body oxidation in the TCA cycle was suppressed in chow-fed as well as in KD-fed diabetic rats, despite ketosis in the KD-fed diabetic rats. Under dobutamine stress, acetoacetate was shunted away from the TCA cycle towards the production of 13 C acetylcarnitine and also stored as 13 C β-OHB (Figure 1 , pathways in blue). We also observed that serum acetoacetate and blood β-OHB increased under dobutamine stress, which could be a result of the reduced ketone body oxidation. These data suggest that ketone bodies are not the preferred substrates under stress. Indeed, we showed that myocardial ketone body oxidation did not correlate with cardiac function parameters under dobutamine stress. Rather, we showed that glycolysis, as indicated by the production of myocardial 13 C lactate upon hyperpolarized 13 C pyruvate injection, was increased under dobutamine stress in KD-fed diabetic rats and chow-fed diabetic rats (Figure 1 , pathways in pink). This observation agrees with established literature that the heart switches to glucose substrate utilization under stress. 33 Dobutamine-induced increase in myocardial 13 C lactate production was also observed in hyperpolarized 13 C pyruvate studies in pigs. 34, 35 In those studies, however, dobutamine also increased 13 C bicarbonate production, while this was decreased in our study, which may be The effects of KD on pyruvate utilization. A, Representative cardiac 13 C MR spectra acquired every 1 second within 1 minute following injection of hyperpolarized [1- explained by the different dobutamine doses. At a high dobutamine dose such as used in the present study, the heart may rely more on glycolysis, as is the case in intense exercise. 36 In the present study, we provide a novel insight that the heart exposed to a low-carbohydrate environment may compensate for the low-carbohydrate availability by upregulating glycolytic reserve capacity. Basal expression of proteins involved in insulin-mediated glucose transport into the heart (i.e. GLUT4) and in the last step of glycolysis (i.e. PKM1 and PKM2) was higher in the hearts of KD-fed diabetic rats than in those of chow-fed diabetic rats. This may translate into an increased capacity to stimulate glycolysis during an increased workload. Indeed, while we observed that myocardial 13 C lactate production upon hyperpolarized 13 C pyruvate injection was increased under dobutamine stress as discussed earlier, it was remarkably higher in the KD-fed diabetic rats than in chow-fed diabetic rats (Figure 1 , pathways in pink). However, the increase in cardiac glycolytic capacity in KD-fed diabetic rats may not be beneficial, as it may further increase a mismatch between glycolysis and glucose oxidation, the latter of which was indeed shown to be lower in KD-fed diabetic rats than in chow-fed diabetic rats.
Diabetic GK rats have been shown to exhibit cardiac diastolic dysfunction, 23 indicating a reduction in cardiac compliance. In the present study, dobutamine stress experiments revealed that KD may further reduce cardiac compliance in the diabetic GK heart. While the vasodilatory effect of dobutamine is expected to reduce preload (and hence EDV via Frank-Starling law) equally in chow-fed and in KD-fed diabetic rats, dobutamine-induced decrease in EDV was less in KDfed diabetic rats. This may indicate increased stiffness of the KD-fed diabetic hearts, which is corroborated by the observed trend for increased myocardial fibrosis on Sirius Red histology. In human studies, failure of dobutamine to induce a > 15% change in end-diastolic LV area 37 or volume 38, 39 has been reported to be associated with the presence of stress-induced regional wall motion abnormality as well as the presence and severity of coronary artery disease. 38, 39 It has also been suggested that the change in EDV was a more sensitive marker of disease than ESV, which is thought to be a relatively more load-independent marker of contractility. 39, 40 In patients with pacinginduced ischaemia, Aroesty et al. showed an earlier increase in LV end-diastolic pressure and less decrease in EDV. 41 As such, we and others 39 believe the attenuated dobutamine-induced decrease in EDV may represent an early rise in end-diastolic pressure (which was not invasively measured in our experiments). The higher EDV in the hearts of KD-fed diabetic rats upon dobutamine stress led to a higher SV and CO in these rats. While one may be tempted to interpret this as an improvement in cardiac function, this may also indicate high output heart failure, 42 especially considering the blunted decrease in EDV upon dobutamine stress. In addition, the high CO was also observed at rest, which could be attributed to the higher resting heart rate in KD-fed diabetic rats compared with chow-fed diabetic rats.
Cardiac hypertrophy has also been reported in the diabetic GK rats, 23 which seems to be exacerbated by KD. In the present study, heart weight, LV mass and cardiomyocyte size were higher in KD-fed diabetic rats than in chow-fed diabetic rats. Interestingly, the further increase in heart weight in KD-fed diabetic rats was accompanied by lower foetal gene expression of pathological hypertrophy markers (Nppa, Nppb, Acta1 and Myh7), suggesting that cardiac hypertrophy in KD-fed diabetic rats might not have been unequivocally pathological. A plausible explanation is that the lower glucose utilization in the hearts of KD-fed diabetic rats may have resulted in reduced expression of these pathological foetal genes, which are typically upregulated in the failing heart in conjunction with an increase in glucose utilization. 43 Interestingly, the expression of GLUT4, PKM1 and PKM2, was increased in the KD-fed diabetic hearts, suggesting that the hearts might be transitioning to a state of glucose substrate preference despite the low glucose environment. The mechanisms mediating the interplay of physiological and pathological hypertrophy are complex. 44 It is possible that cardiac hypertrophy in the KD-fed diabetic rats could ultimately manifest as pathological. This is supported by the observed increase in myocardial lipotoxicity markers observed in the hearts of KD-fed diabetic rats, which play a role in the development of pathological hypertrophy. 45 A very high fat content (95 kcal% fat) in KD raises a concern for lipotoxic cardiomyopathy as found in a high fat diet (HFD, 45% kcal fat). [46] [47] [48] While increased lipid accumulation in the liver has indeed been observed upon KD feeding in wild type mice, [18] [19] [20] little is known about the heart. In HFD feeding, an increase in fatty acid availability which is not paralleled by sufficient increase in the oxidative capacity for fatty acids, may result in the accumulation of lipids and lipid intermediates. [46] [47] [48] Subsequently, this may induce oxidative stress, apoptosis or fibrosis, which in turn impairs cardiac function.
46-48
Indeed, we observed that myocardial TG content tended to be higher in KD-fed diabetic rats than in chow-fed diabetic rats, which may also be due to insufficient increase in fatty acid oxidation, as is the case in HFD feeding. 48 Short-chain fatty acid oxidation was not altered by KD, as observed by similar levels of 13 C glutamate production after injection of 13 C butyrate (Figure 1 , pathways in orange). Because of unavailability of hyperpolarized 13 C substrate for long-chain fatty acids, we were not able to measure myocardial long-chain fatty acid oxidation in vivo. However, the higher expression of ACADL and HADH in the hearts of KD-fed diabetic rats suggests an increase in long-chain β-oxidation, although the expression of CPT1B, which transports long-chain fatty acids into mitochondria, was similar in the hearts of KD-fed diabetic rats and in those of chow-fed diabetic rats.
Serum FFA levels were higher in the KD-fed diabetic rats than in chow-fed diabetic rats, which may suggest an increased FFA availability which is not met by a concomitant increase in the FFA transport into mitochondria. The trend for lipid accumulation in the hearts of KD-fed diabetic rats was also accompanied by a trend for higher collagen content and a significantly higher expression of antioxidant enzyme catalase. Catalase has been shown to be increased in cardiomyocytes with high dietary fat, as higher fatty acid oxidation may lead to higher direct H 2 O 2 production in peroxisomes and mitochondria. 49 The strength of the present study is the use of the 13 C MRS technique using various hyperpolarized metabolic probes, which allows the investigation of cardiac metabolism in vivo. A limitation of the present study is that the control diet and KD
were not matched for protein content, which should be considered for future studies. As KD in the present study consists of very low protein content (5%), the consequences of very low protein content in this study cannot be ruled out. In rats, chronic low-protein deficiency has been shown to promote hypertension and heart failure, 54 while diet with 60% protein content was reported to improve cardiac tolerance of ischaemia. 55 However, a previous study in mice showed that a long-term KD triggered compensation in amino acid metabolism for the decreased protein intake and de novo amino acid biosynthesis, resulting in no premature mortality nor adverse effects of KD on lifespan. 18 In humans, low protein diet has shown benefits in chronic kidney disease, 56 although persistent low protein intake may lead to body functional impairment and increased susceptibility to disease and mortality. 57, 58 It has, however, been acknowledged that the mechanism of ketogenesis might be different in rodents and humans, hence, macronutrients of a ketogenic diet required to induce ketonemia in rodents and humans may be different. 59, 60 The low protein in rodent KD seems to be necessary, as increasing protein content resulted in less ketosis. 59, 60 There is no human diet equivalent to the rodent KD in the present study, 60 with the human KD generally containing higher protein (~20%). Thus, differences in diet composition need to be considered when comparing studies or translating findings to clinical settings.
In light of the growing popularity of KD, our study calls for further investigation into the impact of KD on cardiometabolic health and safety in humans. Our findings and previous studies in mice [18] [19] [20] [21] show that KD may have negative consequences on cardiac and body metabolism, which is relatively unexplored in humans. In humans, KD is generally used as an intervention for body weight loss in obesity, 61 and seems to be effective in the short term but not in the long term. 61 This phenomenon was also observed, interestingly, in the lean diabetic rats in the present study, as well as in the wild-type mice, 18 ,21 which may be explained by increase in fat mass 18, 21 or food intake 19 in the long term. Although the present study was performed on lean diabetic models, the findings may be translated to the setting of obesity, as lean diabetic GK rats display cardiac metabolic phenotypes similar to those in obesity and type 2 diabetes. 62 The main concern is that maladaptation induced by KD may only be revealed via myocardial metabolic changes without compromised cardiac function (unless during stress). Hence, obese patients with diabetic cardiomyopathy, who generally do not exhibit any overt signs or symptoms, 63 may unknowingly subject themselves to the detrimental myocardial effects of KD in the pursuit of body weight loss.
In conclusion, this is the first study to comprehensively investigate the impact of KD on cardiac metabolism in vivo in the diabetic heart, using various hyperpolarized 13 C metabolic probes. In lean diabetic GK rats, long-term KD exacerbated diabetic cardiomyopathy status, which may be associated with maladaptive cardiac metabolic modulation and lipotoxicity. Further research should focus on the cardiovascular safety of KD in humans.
